The Q4 Leishmaniasis (Kala-Azar) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Leishmaniasis (Kala-Azar), provides an update on the mechanism of action and targets, licensing and collaboration opportunities, company profiles including their business information, and market developments.
Leishmaniasis (Kala-Azar) Disease Types, Symptoms, Causes, and Available Treatment Options The comprehensive report on the indication presents Leishmaniasis (Kala-Azar) disease overview, Leishmaniasis (Kala-Azar) types, Leishmaniasis (Kala-Azar) symptoms, causes, and FDA/EMA approved treatment options.
Leishmaniasis (Kala-Azar) Pipeline Trends and Insights The year 2020 witnessed progress in innovations and the number of pipeline agents researched for Leishmaniasis (Kala-Azar) indication. The report presents near-term and long-term pipeline development trends and potential insights.
Leishmaniasis (Kala-Azar) Company Trends and Insights The report analyzes the development progress, current status, investments, partnerships, and other developments of 26 companies. Business profiles and contact details of the companies actively perusing Leishmaniasis (Kala-Azar) pipeline are assessed.
Leishmaniasis (Kala-Azar) R&D Pipeline Development Phase Trends and Insights From the discovery stage of development to phase 3 development, all the potential pipeline drug candidates are analyzed in the report. Leishmaniasis (Kala-Azar) discovery stage, research stage, Phase 1, phase 2, Phase 3, IND enabling studies are provided in the research.
Small Leishmaniasis (Kala-Azar) companies look for licensing and collaboration partners
High R&D costs and long duration pose challenges for small companies operating in the industry. Further, the presence of large companies and stringent regulations act as barriers for Leishmaniasis (Kala-Azar) pipeline development companies. Accordingly, a significant portion of small companies presents potential licensing and collaboration opportunities.
Leishmaniasis (Kala-Azar) Pipeline Market News and Developments during 2020
The Leishmaniasis (Kala-Azar) industry news, pipeline research, market developments including advancement in phases, pre-clinical study results, clinical trial launches, acquisitions and mergers, regulatory approvals, and others are included in the report.
Leishmaniasis (Kala-Azar) Mechanism of Action and Targets Leading Mechanism of Action and targets being researched by all the companies and their progress is included. New mechanisms of actions introduced during the year, route of administration, orphan drug designation, and others are provided in the study.
New molecular entity details Drug candidates identified as new molecular entities by FDA, EMA, and other regulators are included in the research.
Sources and Research Methodology Data is updated daily across diseases in the infectious pipeline service. We review our quarterly pipeline reports for the latest 5 years to present longitudinal insights.
Scope and Coverage • Leishmaniasis (Kala-Azar) pipeline development activities across the early phase, mid-stage, and late phase pipelines including therapeutic candidates
• Drug profiles comprising of drug overview, mechanism of action, co-developers, originators, route of administration, molecule type, orphan drug status, new molecular entity, area, and other details.
• Company-company partnerships, company-institute partnerships, and investment details of companies are included
• 26 companies are included including Acea Biotech Inc, Anacor Pharmaceuticals, Biokawthar Technologies SAS, BioLingus AG, Daiichi Sankyo Co Ltd, DetectoGen Inc, GlaxoSmithKline Plc, iCo Therapeutics Inc., Immune Modulation Inc, Impetis Biosciences Ltd, Laboratorios LETI SL, ManRos Therapeutics, Matinas BioPharma, MedC Biopharma Ltd, Mind Medicine Inc, Molecular Targeting Technologies Inc, Mycosynthetix Inc, NanoCliq LLC, Nanomerics Ltd, Novartis AG, Oblita Therapeutics BVBA, Pai Life Sciences Inc, Pfizer Inc, Pharos I&BT Co Ltd, Rakta Therapeutics Inc, Synstar Japan Co Ltd,
• Disease overview, Pipeline trends, market analysis, and other developments
• Potential licensing/new business opportunities in Leishmaniasis (Kala-Azar) pipeline market
Highlights • Global coverage of companies and pipeline agents
• 2020 Trends, market analysis, and developments
• Potential growth opportunities
• Comprehensive details of drug candidates
Reasons to Buy • Drive pipeline research and commercial assessment
• Assess most promising drug candidates and stay ahead of the competition
• Strengthen your pipeline through identifying business expansion and acquisition opportunities
• Develop new candidates based on most focused targets and mechanism of actions
Our reports have been used by over 10K customers, including:
129 pages •
By Global Industry Analysts
• Aug 2021
Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC and SLM Solutions Group AG. The global 3D printed implants market is expected to grow from $0.14 billion in 2020 to $0.15 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies...
Anatomic Pathology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology types, applications. Further, Anatomic Pathology...
Anatomic Pathology Track and Trace Solutions market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Track and Trace Solutions Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology...
Pathology Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pathology Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pathology Devices types, applications. Further, Pathology Devices...
The global apheresis equipment market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The global arthroscopy devices market exhibited moderate growth during 2015-2020. Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body. They are primarily used for the treatment of medical conditions,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.